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role of  dermal substitutes[1,2] and no material has yet been 
described that fulfills all the ideal features.
The clinical performance of  wound dressings and dermal 
substitutes based on synthetic biomaterials is limited to the 
ability of  these polymers to keep the wound environment 
moist, to protect the wound site from infections and in some 
cases to encourage cell colonization.[3-6] Natural polymers 
of  human and animal origin bear biochemical features that 
can favor the healing processes. Indeed, biomaterials based 
on protein or polysaccharide composition such as collagen, 
glycosaminoglycans, agarose, alginate, chitosan and fibrin 
glue have been shown to be able to promote interactions 
with biochemical and cellular components leading, for 
Introduction
Bioengineered products able to support the healing of  
chronic ulcers, deep wounds and burns are in increased 
demand to improve patients’ quality of  life and survival rate. 
Many different biomaterials have been investigated for the 
A B S T R A C T
In the last decade, a new class of natural biomaterials derived from de-fatted soybean ﬂ our processed by either thermoset or 
extraction procedures has been developed. These biomaterials uniquely combine adaptability to various clinical applications to 
proven tissue regeneration properties. In the present work, the biomaterials were formulated either as hydrogel or as paste for-
mulation and their potential as wound dressing material or as dermal substitute was assessed by two in vivo models in pig skin: 
The healing full-thickness punch biopsy model and the non-healing full-thickness polytetraﬂ uoroethylene (PTFE) chamber model. 
The results clearly show that collagen deposition is induced by the presence of these biomaterials. A unique pattern of early inﬂ am-
matory response, eliciting neutrophils and controlling macrophage inﬁ ltration, is followed by tissue cell colonization of the wound 
bed with a signiﬁ cant deposition of collagen ﬁ bers. The study also highlighted the importance in the use of optimal formulations 
and appropriate handling upon implantation. In large size, non-healing wounds, wound dermis was best obtained with the paste 
formulation as hydrogels appeared to be too loose to ensure lasting scaﬀ olding properties. On the contrary, packing of the granules 
during the application of paste reduced biomaterial degradation rate and prevent the penetration of newly vascularized tissue, thus 
impeding grafting of split-thickness autologous skin grafts on the dermal substitute base.
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example, to hemostatic functions (e.g., alginate and fibrin) 
and to bioligand-driven cell activity control (e.g., collagen and 
hyaluronan). However, the use of biopolymers in regenerative 
medicine is limited by their antigenic potential, by the risks 
of  transmittable diseases, by batch-to-batch variability and, 
in some cases, by their relatively high extraction costs.
For example, collagen-based materials have been investi-
gated more extensively as scientists tried to produce dermal 
substitutes mimicking normal skin where dermal collagen 
plays very important roles in structure and function. Ini-
tially, raw human or animal skin, either fresh or frozen, was 
used to cover wounds but immunological reactions were 
soon observed leading to poor experimental and clinical 
performances.[7] These immunological reactions were at-
tributed to the presence of  cellular component and led to 
the use of  decellularized dermal sheets. These showed no 
rejection upon implantation while providing solid dermal 
wound bed for the later application of  split-thickness skin 
grafts.[7-9] Although this approach has been clinically suc-
cessful, it still brings drawbacks that need to be resolved. 
First, there is a problem of  transmissible diseases. Although 
donors are screened extensively and manufacturing pro-
cesses minimize such a possibility, risks still exist. Ethical 
issues have also to be considered as important for some 
religious groups.[10] Furthermore, the logistics, suitable 
donor selection, coordination of  skin banks networks and 
the storage of  human-derived products are all major issues 
associated with this approach and limiting its use. Dermal 
substitutes of  non-human origin like Integra®, Matriderm® 
and Terudermis®, although still expensive to produce and 
store, are less subject to the ethical and cross-contamination 
issues since animals have an interspecies resistance to some 
viral disease.
In the last decade, a new class of  natural biomaterials de-
rived from de-fatted soybean flour processed by thermoset 
or extraction procedures has been developed.[11] These 
biomaterials uniquely combine adaptability to various 
clinical applications to clear tissue regeneration properties. 
Formulations can be easily prepared that span from films 
and granules to hydrogels and pastes or bioglues. In vitro 
studies on fibroblasts, osteoblasts and macrophages as well 
as in vivo studies of  bone regeneration have clearly dem-
onstrated the healing properties of  these biomaterials.[12-16]
These biomaterials need to be distinguished from those 
based on soy protein only.[17,18] Soy protein scaffolds, for 
example, have been fabricated using freeze-drying and 
3D printing and tested for their biocompatibility in vivo 
by a subcutaneous implant model in mice.[19] The study 
compared the soy protein with bovine collagen in terms of  
acute and humoral immune response showing that soy scaf-
folds fully degraded after 14 days with no sign of  fibrosis 
as opposed to collagen scaffolds that remained intact for 
56 days. Immunological analysis showed no soy-specific 
IgE indicating the absence of  allergic response to the soy 
implants. Likewise, a rat wound-dressing model of  partial-
thickness skin wounds was used to study newly developed 
chitosan/soy-based membranes as wound dressing mate-
rials showing high healing properties of  these materials 
when compared to a commercially available dressing such 
as Epigard®.[20]
This paper shows for the first time the healing properties 
of  soybean-based hydrogels and pastes in 2 pre-clinical 
in vivo models based on healing (full-thickness punch biopsy 
model) and non-healing (full-thickness chamber model) 
wounds in pigs.
Porcine animal models have been widely utilized for wound 
healing and skin regeneration studies as the most similar 
to the relative clinical applications.[21] The use of  punch 
biopsies to create experimental wounds has been described 
for several animal models, including guinea pig for skin 
studies.[22] Punch biopsy models in pigs were also used for 
skin wound healing studies.[23-25] A percutaneous polytetra-
fluoroethylene (PTFE) full-thickness wound chamber pig 
model has also been previously used in many studies such 
as those assessing biointegration of  different types of  bio-
materials and skin cells and has shown excellent results.[26]
Materials and methods
Material preparation
Soybean-based biomaterials were prepared from de-fatted 
soybean flour as previously described.[12] Briefly, soybean-
based hydrogels were obtained by extraction of  soybean 
protein, carbohydrate and isoflavone fraction through a 
80/20% ethanol/water extraction process. The extracts 
were filtered, freeze-dried, reconstituted in a minimum vol-
ume of  0.1M CaCl
2
 solution to obtain a hydrogel. Granules 
of  soybean-based biomaterials were obtained by thermo-
setting of  soybean curd at 60oC for 20 h. The thermoset 
material was then grinded in a blender and granule size 
selected by filtering through stainless steel filters to achieve 
a controlled granule diameter within the 215-300 μm range. 
Two paste formulations were obtained mixing granules with 
hydrogels without or with genipin cross-linking as it follows:
1. Soybean-based granules (40%) and soybean-based 
hydrogel (60%).
2. Soybean-based paste cross-linked with 1% (w/v) 
genipin.
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Figures 1a-d show typical  soybean paste  non-cross-linked 
[Figure 1a] and cross-linked paste [Figure 1b] formula-
tions and a typical application to PTFE chamber model 
[Figures 1c and d].
In vivo Experiments
Two types of wound models were adopted [Figures 1d and e]. 
All experiments were approved by a local ethical review 
committee and carried out according to the “Animals (Sci-
entific Procedures) Act 1986” under Home Office project 
license PPL 80/1735 and personal license PIL 80/8828 
granted on 1/10/2004.
Full-thickness biopsy model
Three pigs were used for this study, and the total number of  
experimental wounds was 72, with 24 per animal. The study 
was carried out in two experimental stages. As a first stage, 
biointegration of biomaterials was assessed in one animal. The 
second stage included the assessment of the wound healing 
properties of  soybean-based biomaterials in two animals. 
The healing process starts immediately after wounding but 
the most active proliferative phase occurs between 5 and 
21 days with maximum effect between the 7th and 14th day. 
As a consequence, punch biopsies were taken at two time 
points: 8 and 15 days post-implantation. Sample evaluation 
of integrated materials at day 27 was performed to assess the 
relatively long-term performance of the applied materials. A 
10 mm punch was used to harvest biopsies. Upon removal, 
each biopsy was bisected vertically, one-half was processed to 
paraffin wax embedding by routine automated procedures and 
the other half was frozen for cryo-sectioning. Paraffin sections 
(5 μm) were stained with hematoxylin and eosin (HE) to reveal 
basic structure of the tissue, and with picrosirius red (PSR) for 
collagen deposition visualization. Birefringence images were 
also taken to study collagen orientation.
Full-thickness chamber model
Seven large white/landrace crossbred pigs obtained from a 
single registered supplier were used for this study. A total of  
42 experimental wounds were created with 6 per animal. 
Wounds were treated with soybean-based biomaterials 
in addition to a number of  alternative biomaterials (data 
published elsewhere).
Two circular skin grafts 5 cm in diameter and 500 μm thick 
were harvested and reapplied to the excised wound serv-
ing as a control treatment group. The epithelial layer was 
trimmed with a Zimmer air dermatome (setting 3, 6/1000th 
of  an inch) before dermal harvest was performed. Fat was 
trimmed off  the wound bed with a scalpel and dermis was 
reapplied to the wound and sutured in place.
Negative control wounds did not receive any specific treat-
ment and were left to form a layer of  granulation tissue.
In a preliminary study, two pre-measured 1.3 ml volumes 
of  soybean-based hydrogels were spread evenly by spatula 
on top of  the wound to form a layer approximately 1 mm 
thick. The lack of  consistency and long-term stability of  the 
hydrogel prompted the development of  two new soybean-
based paste formulations that were tested in combination 
to split-thickness autologous skin grafts.
Paste (1.3 ml) was extruded from a syringe, and a circular 
layer of  approximately 5 cm in diameter and 1 mm thick 
was then formed with a spatula.
Split-thickness autologous skin graft approximately 5 cm × 
5 cm × 0.015 cm was harvested with an air-driven Zimmer 
air dermatome. The graft was trimmed to a circular shape 
and was applied to granulating wounds at day 0 or 6 (posi-
tive control) or applied over dermal substitute biomaterials.
Following biomaterial implantation and skin graft fixing 
by Appose® and Autosuture® skin staples, each chamber 
was dressed with a double layer of  Telfa Clear® fenestrated 
non-adherent silicone dressing.
To use the chamber model more effectively and to reduce 
number of  animals, serial intrachamber punch biopsies were 
taken with a final whole wound excision biopsy. Taking 
such biopsies at different time points allowed assessment 
of  the time of  biointegration and the most appropriate time 
for split-thickness skin grafting for each biomaterial based 
on progression of  the neovasculature network formation.
Wound dressings were changed every 3 days with simul-
taneous clinical wound assessment. Full-thickness wound 
Figure 1: Soybean-based dressing formulations. (a) Non-cross-linked 
paste (60% by weight soybean thermoset granules and 40% by weight 
hydrogel), (b) genipin cross-linked paste, (c-d) typical application 
procedure on pig model, (e) punch biopsy model, (f) PTFE chamber 
model.
a
e f
b c d
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excision biopsies were done at day 3, 6 and 14. Three 
5.0 mm punch biopsy samples (top, middle and bottom 
of  the wound) within each chamber were taken to assess 
material integration. The same procedure was repeated on 
day 4 and 7. On day 14, wounds were harvested by exci-
sion and 10 mm biopsies were taken within harvested tissue 
samples. Upon removal, each biopsy was bisected vertically, 
one-half  was processed to paraffin wax embedding by rou-
tine automated procedures and the other half  was frozen 
for cryo-sectioning. Paraffin sections (5 mm) were stained 
with HE to reveal basic structure of  the tissue and with PSR 
for collagen deposition visualization. Cryo-sections were 
processed for immunohistochemical staining by incuba-
tion in a humidified chamber for 20 min with normal goat 
serum (Sigma-Aldrich Company Ltd., UK) and a further 
hour with the primary rabbit anti-human von Willebrand 
factor polyclonal antibody (anti-vWF, DakoCytomation, 
UK) used at a 1:40,000 final dilution to identify blood vessel 
formation. To study the epithelial cover, cryo-sections were 
also processed for immunofluorescent staining with mouse 
monoclonal anti-human cytokeratin 14 (clone LL002) anti-
body at a 1:50 dilution. Rabbit anti-human von Willebrand 
factor polyclonal antibody (1:200 concentrate) was used 
at 1:200 dilution to identify blood vessel formation. Mac-
rophage/L1 Protein/calprotectin Ab-1 (clone MAC 387) 
antibody was used at 1:40 dilution for tissue macrophage 
visualization. Tissue sections were washed with PBS and 
incubated for one further hour with secondary antibody 
fluorescein-isothiocyanate (FITC)-labeled goat anti-rabbit 
IgG (MP Biomedicals, UK) at 1:100 dilution as recom-
mended by the supplier.
The stained tissue sections were viewed and analyzed 
through a fluorescent microscope, Olympus BH2, and 
photographed within 24 h of  staining using a Spot 1.1.0 
digital camera (Diagnostic Instruments, Inc., USA) and 
Image-Pro Plus software (Media Cybernetics, Inc., USA). 
Digital photographs of  histological tissue sections were 
loaded into Image-Pro Plus 4.0 image analysis software 
package (Media Cybernetics, Inc., USA) and a grid mask 
was superimposed over the image. Area, depths and host 
cellular migration and neovascularization of  the implanted 
biomaterials were evaluated by counting elements of  inter-
est, either manually or automatically in 5 fields of  view of  
each tissue section at magnification ×100 (cellular migra-
tion), ×40 (neovasculature in-growths) or ×20 (granulation 
tissue formation). Statistical analysis was performed in 
SigmaStat 3.5 (Systat Software, Inc., USA) using either 
t-test Student’s or one-way analysis of  variance (ANOVA) 
with the further post-hoc analysis between groups (Tukey 
test). P-values with less than 0.05 between tested groups 
were considered to be statistically significant.
Clinical digital photographs of  all experimental wounds 
where epithelial treatment was applied (n = 27) were loaded 
into Image-Pro Plus 4.0 image analysis software package 
(Media Cybernetics, Inc., USA), and the total area of  the 
wound and the area of  epithelialization were digitally traced 
and quantified. Epithelialization was expressed as a percent-
age ratio of  the epithelialized area to the total wound area.
Tissue microphotographs were arranged into montage 
panels (each consisting of  15-50 individual images) to 
reveal the entire cross-section of  the excised experimental 
wound. Levels of  epithelialization, inflammation, 
neovascularization and granulation tissue formation were 
assessed at magnifications ×20, ×40, ×100 and ×200 either 
qualitatively or quantitatively with the help of  an image 
analysis software. Obtained data were analyzed statistically 
using ANOVA with pair-wise multiple comparison of  
experimental groups (Tukey Test) and differences between 
groups were considered to be statistically significant at 
P < 0.05.
Results
Full-thickness biopsy model
The full-thickness biopsy model showed that control 
wounds rapidly healed with epithelialization as expected 
in this animal model. A reduction in acute inflammatory 
response was observed with time in all wounds [Figure 2a]. 
An inflammatory infiltrate was visible on day 8, but it was 
greatly reduced by day 15 [Figures 2a and b, inserts]. PSR 
staining also showed clear deposition of  new collagen 
Figure 2: Histology of control wounds in the punch biopsy model (×20). 
(Scale bar=1000 μm) (a and b) Day 8 of healing (c and d) and day 15 
of healing. Hematoxylin and eosin staining (a and c) and Picrosirius 
staining (b and d). (a and c) Inserts in (a) and (c) highlight high 
magniﬁ cation (×200) images of area of inﬂ ammatory cell inﬁ ltration. (d) 
Insert highlights birefringence image showing newly deposited collagen 
ﬂ uorescing green at the interface with the graft.
a
c
b
d
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visible as small fibers fluorescing green by birefringence 
microscopy. This was shown by either a thin boundary 
of  collagen birefringence [Figure 2c, rectangle] or clearly 
observed as a distinct area [Figure 2d, rectangle].
All the wounds treated with soy-containing biomaterials 
showed signs of  inflammation after 8 days of  implantation 
[Figure 3a] with the presence of  the implanted hydrogel 
still visible within the wound site [Figure 3a, arrow]. This 
acute inflammatory reaction toward the soybean-based 
hydrogel was resolved by day 15 and the material resulted 
completely re-absorbed and tissue cells have populated the 
wound site depositing new extracellular matrix [Figure 3b]. 
The deposition of  the new collagen was clearly showed by 
birefringence microscopy [Figure 3c] at a level comparable 
to that of  the control [Figure 2d]. Experimental wounds 
treated with soybean-based hydrogel did not seem to resist 
contraction due to the lack of  mechanical stiffness of  the 
implanted hydrogel material.
Full-thickness chamber model
No bacterial wound contamination or chamber extrusion 
was observed and therefore all wounds were made avail-
able for analysis.
Control wounds showed no epithelialization, neither by 
clinical visual inspection nor by histological analysis (data 
not shown).
In the preliminary study, soybean-based hydrogel tended to 
run slowly down the vertical surface of  the wound although 
it remained in place when silicone dressing was applied 
(data not shown). The first dressing change procedure 
performed on day 2 revealed macroscopic absence of  the 
applied soybean-based hydrogel material in the wounds. 
No soybean-based hydrogel was seen in histological sec-
tions from day 2 and thereafter and no direct biomaterial 
visualization was possible to quantify host cell penetration 
or scaffold neovascularization. Other detectable effects of  
soybean-based hydrogel application, like collagen depo-
sition, were marginally increased when compared with 
control wounds [Figures 4a and b, arrows]. This relatively 
thin tissue layer was directly apposed on the muscle layer. 
Visual inspection of  the wounds treated with soybean-based 
hydrogel showed granulation tissue formation at the sites of  
biomaterial implantation. The thickness of  the granulation 
tissue layer proceeded from 0.26 mm (SD = 0.19) on day 
4 to 1.19 mm (SD = 0.71) on day 7 [Figure 4b], and to 4.8 
mm (SD = 3.24) on day 14 (data not shown).
For these reasons, further experiments were performed 
with the soybean-based paste that provided information 
for optimizing the handling properties of  the material 
and its stability in the wound thus also giving the oppor-
tunity of  evaluating its skin grafting substrate properties. 
Unlike the previously assessed soybean-based hydrogel 
formulation, the soybean-based paste biomaterial proved 
to persist in the wound during the course of  the experi-
ment [Figures 5d-i].
Control split-thickness skin grafts applied directly to the 
wound bed survived and integrated into the wound when 
applied as early as day 0. Histological assessment revealed 
well-structured epithelium with an undulating basal layer 
Figure 3: Histology of soybean-based hydrogels in the punch biopsy 
model (×20). (Scale bar=1000 μm) (a and b) Day 8 of healing (c and 
d) day 15 of healing. Hematoxylin and eosin staining (a and c) and 
Picrosirius staining (b and d). (a and c) Inserts in (a) and (c) highlight 
high magniﬁ cation (×200) images of area of inﬂ ammatory cell inﬁ ltration. 
(d) Insert highlights birefringence image showing newly deposited 
collagen ﬂ uorescing green at the interface between the graft and the 
area of hydrogel implantation.
a
c
b
d
Figure 4: Soybean-based hydrogels in the PTFE chamber wound model 
after 2 days of implantation. (Scale bar=100 μm) (a and b) Histological 
analysis by hematoxylin and eosin staining of non-treated wound (a) and 
soybean hydrogel (b). Insert in (a) shows visual inspection of the wound. 
Arrows indicate a newly formed tissue layer deposited on the muscle layers.
a
b
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and multiple deep rete ridges [Figure 5a]. The epithelial 
nature of  cells was confirmed by positive immunostaining 
for cytokeratin-14 [Figure 5a, insert]. Granulation tissue 
formation was minimal in these control wounds. The epi-
thelialized area was 71.28%, SD = 17.19 on day 14. The 
influx of  phagocytic leucocytes was relatively limited.
The soybean-based paste was clearly visible in the wound 
clinically (data not shown) as well as histologically from day 
2 to 14 [Figures 5-7]. On day 2, HE staining clearly showed 
the prevalence of  polymorphonucleate cells gradually infil-
trating the material granules from the bottom of  the wound 
upward and degrading them both in non-cross-linked and 
cross-linked pastes [Figures 5d, f, g, i, asterisks]. MAC387 
staining clearly show that the presence of  macrophages 
was very limited [Figure 5f, insert]. The deposition of  new 
tissue observed on day 2 was negligible [Figure 5e and h] 
and the split skin graft did not graft onto the biomaterial 
bed in most of  the cases [Figures 5d and g].
This pattern gradually evolved on day 6 when control split 
graft showed no significant improvement of  integration 
[Figures 6a-c], while polymorphonucleates progressed 
toward the top of  the wounds treated with both non-cross-
linked and cross-linked soybean-based pastes [Figures 6d 
and g]. However, deposition of  new collagen gradually infil-
trating the granules from the bottom of  the wound upward 
was clearly observed by both PSR staining and birefringence 
microscopy [Figures 6d, e, g, h]. The latter highlighted rela-
tively thick fibers (orange birefringence), which is typical 
of  more mature collagen. This newly formed extracellular 
matrix appeared to replace the granulocyte-rich infiltrates. 
Where still present, these cells lead to a more pronounced 
degradation of  the biomaterial granules [Figures 6f  and i].
This pattern of  healing was even more clearly observed 
on day 14 [Figures 7a-i]. At this point, experimental 
wounds with applied soybean-based paste revealed two 
distinct patterns of  vascularization; soybean-based paste 
showing relatively compacting of  granules did not show 
vascular in-growth deeper than 200-300 μm [Figure 7a], 
whereas wounds with dispersed soybean-based particles 
were infiltrated by new microvasculature throughout 
their thickness [Figures 7d and g]. The degree of  col-
lagen deposition followed the same pattern with the less 
compacted granules allowing a full penetration of  new 
extracellular matrix [Figures 7b and c]. High magnifica-
tion histology clearly showed the infiltration of  collagen 
fibrils throughout the granules and within their degrading 
structure [Figure 7h], while birefringence clearly showed 
their ordered structure [Figure 7i].
Discussion
Skin damages generated by pathologies or trauma require 
the support of  wound dressing and dermal substitutes ca-
pable of  encouraging tissue regeneration while protecting 
the wound bed from infections and dehydration. Unless 
expensive and potentially carcinogenic growth factors are 
uploaded in the hydrogel mesh,[27] wound dressings are of  
Figure 5: Soybean-based pastes in the PTFE chamber wound model 
after 3 days of implantation. (a-c) Control wound with applied split-
thickness autologous graft, (d-f) non-cross-linked paste of Figure 1a, 
(g-i) cross-linked paste of Figure 1b. (b, e, h) Picrosirius staining, while 
all remaining images show hematoxylin and eosin staining at different 
magniﬁ cations. Insert in (a) shows keratinocyte immunostaining, insert 
in (f) shows immunostaining for macrophages (MAC387 antibody). 
Asterisks indicate soybean-based paste granules. Scale bar: a, d and 
g, 200 μm; b, e and h, 1000 μm; c and f, 100 μm; i, 20 μm.
a
d
g
b
e
h
c
f
i
Figure 6: Soybean-based pastes in the PTFE chamber wound model 
after 6 days of implantation. (a-c) Control wound with applied split-
thickness autologous graft, (d-f) non-cross-linked paste of Figure 1a, 
(g-i) cross-linked paste of Figure 1b. (a, d, g) Picrosirius staining, (b, e, h) 
Birefringence microscopy, (c, f, i) hematoxylin and eosin staining at high 
magniﬁ cation showing polymorphonucleate inﬁ ltrates degrading paste 
granules. Asterisks indicate soybean-based paste granules. Scale bar:
a, d and g, 200 μm; b, e and h, 1000 μm; c and f, 100 μm; i, 20 μm.
a
d
g
b
e
h
c
f
i
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relatively simple composition and design as they are primar-
ily engineered to keep the wound moist, oxygenated and 
protected by external microbial insults. For these reasons, 
wound dressings are mainly used in the treatment of  chronic 
foot and leg ulcers as well as in the case of  burns of  limited 
area surface. Their ability to promote healing is very limited 
in the case of  chronic ulcers as those occurring in diabetic 
patients or in the case of  pressure ulcers as those caused by 
long-term dwelling in static positions.
Dermal substitutes (acellular and cellularized) have been 
made available to clinicians to intervene on large-area 
wounds and burns.[28]
Recent investigations about the use of  soybean as a potential 
source for biomaterials have highlighted that these biomate-
rials in the form of  films, granules, hydrogel or paste exert 
several specific bioactivities on various types of  tissue cells 
and promote bone regeneration in vivo.[14,15] Previous studies 
have also shown that these tissue regeneration properties 
can be ascribed to the unique combination of  the scaffolding 
properties of  these biomaterial and presence of  isoflavones, 
plant estrogens capable of  selectively interacting with the 
estrogen receptor (ER) β of  the nuclear membrane rather 
than the ERα, thus activating cell differentiation rather than 
proliferation with a consequent induction of  the production 
of  extracellular matrix components, that is, collagen.[12,16] In-
terestingly, it is known that skin is the largest non-reproduc-
tive system target for estrogens and their effect is executed 
through nuclear estrogen receptors ERα and ERβ.[29] ERβ 
is particularly widespread in skin and expressed in basal 
keratinocytes, bulge region of  hair follicles and papillary 
dermis.[30,31] The lack of  estrogens results in skin thickness 
reduction, skin dryness, loss of  elasticity and poor wound 
healing.[29,32,33] Activation of  ERα and ERβ keratinocyte 
receptors as well as reported transactivation of  epidermal 
growth factor (EGF) receptor by estrogens[34] may explain 
estrogen-induced keratinocyte proliferation.[35,36] Estrogens 
were found to reduce apoptosis, induced by the oxidative 
stress in human keratinocytes.[37] Estrogens also exhibit 
their effect on dermal component of  the skin by increasing 
fibroblasts proliferation. These observations prompted the 
pre-clinical validation of  the soybean-based biomaterials 
when formulated as hydrogel or as paste (mix of  thermoset 
granules and hydrogel) and to the purpose of  using them 
either as wound dressing material or as dermal substitute 
to support split-thickness skin grafts in burns or other types 
of  extended skin loss.
The use of  two in vivo models of  skin regeneration in pigs 
clearly highlighted the ability of  these natural biomaterials 
to reduce a chronic inflammatory response driven by 
macrophages common to many other biomaterials and 
to stimulate the deposition of  collagen during the healing 
process. These findings confirmed previous in vitro studies 
showing the inhibition of  macrophages and the stimulation 
of  fibroblast collagen synthesis by these biomaterials.[12,16] 
In particular, a healing model such as the full-thickness 
punch biopsy showed that soybean-based hydrogels of  a 
relatively loose consistency are suitable for the treatments 
of  relatively small and deep defects such as those of  chronic 
foot ulcers. The fluidity of  the biomaterial allow its in-depth 
penetration into the wound bed where it stimulates the acute 
inflammation in the early phase and stimulate a gradual 
deposition of  new extracellular matrix where collagen 
fibers acquire an orientation similar to that of  the healthy 
dermis. The fluidity of  the hydrogel also support wound 
contraction, a process that is fundamental to wound closure.
However, the same hydrogel formulation was shown to 
be not suitable for the treatment of  large defects as it was 
not able to offer sufficient and stable scaffolding role for 
the regenerating tissue. Toward this end, a soybean paste 
consisting of  a mix of  granules derived from the thermo-
setting of  soybean curd and of  the same hydrogel was 
used as such or further reinforced by cross-linking with a 
natural dialdehyde, the genipin. These new paste formula-
tions were used in the non-healing full thickness chamber 
model where a PTFE ring prevents tissue in-growth from 
the periphery of  the wound bed and allows regeneration 
Figure 7: Soybean-based pastes in the PTFE chamber wound model 
after 14 days of implantation. (a-c) Typical soybean-based paste tissue 
regeneration proﬁ le throughout wound depth. (d-f) Typical soybean-
based paste tissue regeneration proﬁ le close to the wound bed. (g-i) 
Typical soybean-based paste tissue regeneration proﬁ le showing details 
of new extracellular matrix deposition among degrading granules. (a, d, 
g) Von Willebrand immunostaining showing degree of neovascularization 
in paste with compacted granules (a) and dispersed granules (d, g). (b, 
c, e, h) Picrosirius staining, (f, i) birefringence microscopy. Asterisks 
indicate soybean-based paste granules. Scale bar: a, d and g, 500 μm; 
b and e, 1000 μm; c and f, 1000 μm; h and i, 500 μm.
a
d
g
b
e
h
c
f
i
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only from its bottom. The experiments clearly showed that 
the two types of  pastes could ensure stability and tissue 
scaffolding properties over a longer period of  time as they 
were still present after 25 days of  implantation. Uniquely, 
the fast degradation of  the hydrogels was creating space 
among the more stable granules that gradually encour-
aged tissue infiltration, first in form of  acute inflammatory 
response exhibiting a prevalence of  neutrophils to that of  
macrophages, later inducing the thorough invasion of  new 
dermis where collagen and vessels gradually progressed 
from the bottom of  the wound toward its surface. How-
ever, the data also showed that the optimal formulation of  
the paste is as important as its biocompatibility and tissue 
regeneration properties. In fact, when granules were exces-
sively packed in the wound bed during the surgical proce-
dure, tissue in-growth was delayed or even substantially 
inhibited. This was detrimental not only for the process of  
infiltration of  newly deposited collagen and blood vessels, 
but also for the survival of  autologous skin grafts applied 
on the biomaterial-treated wounds. Only when spacing 
among granules were ensured, split grafts were capable of  
surviving and integrating with the surrounding healthy tis-
sue, encouraging both collagen formation and angiogenesis.
The present pre-clinical study clearly shows the tissue 
regeneration potential of  soybean-based biomaterials. The 
use of  these biomaterials present a number of  potential 
advantages including:
1. A degradation time faster than collagen-based 
biomaterials;[19]
2. An inflammatory response maintaining the neutrophil/
macrophage balance in favor of  the neutrophils, thus 
reducing the risks of  infections and of  a chronic 
inflammation leading to scarring;[16,19]
3. The stimulation of  collagen synthesis and angiogenesis 
promoting tissue repair in wounds not capable of  
spontaneous healing.
Together with the relatively simple manufacturing process 
of  these biomaterial and flexible formulations, these prop-
erties highlight the clinical potential of  these biomaterials 
that can represent a unique alternative to less performing 
dressings and dermal substitutes. However, the study also 
indicates that the clinical outcome of  wounds treated by 
these biomaterials relies on the optimal design of  their 
formulation and correct use by the practitioners.
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